Krur 2025: Reported earnings weakened, but the story has already shifted to Yafora and cash allocation

Knowing the Company

At first glance, Krur still looks like a legacy food and beverage holding company. In the 2025 report it still contains Yafora, the stake in Tifugan, and the remains of the Green Pet recycling experiment. But that is no longer the right way to read it. By the time this report was published, Tifugan had already been sold on January 1, 2026, Green Pet had already been classified as a discontinued operation, and the real core of the story had narrowed to Yafora’s beverage platform and the question of what Krur will do with the cash that was unlocked.

That is also why the accounting headline is misleading on its own. Consolidated net profit fell 58.4% to NIS 42.7 million, which looks very weak on paper. That is the wrong first read. The split underneath matters more: continuing operations still produced NIS 82.7 million of profit, while discontinued operations subtracted NIS 40.1 million, mainly because of Green Pet. Anyone reading Krur only through the bottom line is missing the move from a more complicated holdings structure to a far more focused company.

What is still working? The beverage core remains profitable, carries strong brands, and has nationwide distribution with no single customer above 10% of sales. Revenue from continuing operations fell 5.2% to NIS 790.2 million, mainly because the distribution of Mey Eden products ended, yet gross margin actually improved to 48.0% from 47.5%. That matters because it says the core business did not break. It became narrower and more selective.

What is still not clean? The bridge between group value and value that actually reaches Krur shareholders. On December 31, 2025, Tifugan still sat on the balance sheet as a held-for-sale investment worth NIS 84.1 million. One day later it had already turned into NIS 163.5 million of immediate cash to Krur and another NIS 43.7 million due on January 1, 2027. That is a major change, but it also shifts the debate from “what are the assets worth?” to the much harder question of “how much cash really reaches the parent, how quickly, and what will management do with it?”

There is also a practical screen constraint that the market does not always like to admit. Krur’s market cap is about NIS 1.08 billion, but the latest daily trading turnover was only about NIS 85 thousand. Short interest stood at just 0.03% of float, below the sector average. This is not a stock where shorts are driving the tone, and it is not a stock where a good story necessarily reprices quickly. The path here runs through reports, distributions, and capital allocation, not tactical trading.

Krur’s economic map now looks like this:

Events and Triggers

Trigger one: the Tifugan sale is no longer a scenario. It is done. The transaction closed on January 1, 2026, and Krur’s share of the consideration was NIS 163.47 million in immediate cash plus another NIS 43.71 million due one year later. The 2025 report still carries no P&L impact from the deal, but it already contains the key signal: a capital gain of about NIS 123 million before tax is expected to be recorded in Q1 2026. The market will get a strong headline quickly, but that headline will not tell investors what the recurring earnings base looks like without Tifugan.

Trigger two: Green Pet moved in 2025 from a strategic option to an expensive reminder of the limits of expansion. In the first stage, on November 25, 2025, the PET sorting and washing line was shut down. In the second stage, on December 28, 2025, the RPET line was also stopped, so the operation was effectively shut altogether. This was not cosmetic. During the first nine months of 2025, Green Pet lost NIS 15.9 million. In Q3, the group booked NIS 26.3 million of impairment. In Q4, it booked another roughly NIS 7.6 million. Total 2025 impairment reached about NIS 33.9 million.

Trigger three: the end of Mey Eden distribution is still distorting the read on 2025. Management explicitly says the termination had a materially negative effect on Yafora’s results, but also says compensating actions absorbed most of the damage. That phrasing matters. It means the beverage core managed to absorb a large part of the hole, but not yet to post such clean growth that the gap fully disappeared.

Trigger four: the agreed administrative fine of about NIS 12.18 million to the Competition Authority did not change Krur’s strategy, but it did change the tone of the fourth quarter. It turned what could have looked like a relatively orderly transition year into a reminder that Yafora’s core business still carries regulatory and commercial friction, not just industry competition.

Trigger five: the extension of Roni Gat’s unpaid leave through March 31, 2026 is not the center of the thesis, but it is a governance signal worth keeping in mind. Krur is entering a phase where capital allocation matters more than the old asset mix, and that happens while the active chairman of Yafora and Yafora-Tavori is temporarily away. That is not a thesis by itself, but it is not pure noise either.

What matters most is the sequence, not any single event on its own. Krur entered 2025 with a portfolio that still included a beverage core, a profitable Tifugan stake, and a recycling activity that could still be framed as strategic optionality. It exits the year with a much simpler equation: beverages remain, Tifugan has been monetized, and Green Pet has been shut down. In other words, Krur has exchanged operating complexity for capital-allocation complexity.

Efficiency, Profitability and Competition

The key point is that the revenue decline did not translate one-for-one into gross erosion, but it did translate into operating pressure. Revenue fell to NIS 790.2 million from NIS 833.1 million, while gross profit slipped only to NIS 379.0 million from NIS 395.5 million. Gross margin even improved, from 47.5% to 48.0%. That typically happens when what disappears is lower-quality or lower-margin volume, which fits the loss of Mey Eden distribution and the company’s own statement that water and soda carry lower gross profitability than sweet beverages.

But the improvement stopped at the operating line. Operating profit fell 18.6% to NIS 87.7 million, and operating margin compressed to 11.1% from 12.9%. Part of that came from the competition fine, which turned a previously positive “other income and expenses” line negative in 2025. Another part came from higher G&A and weaker net finance income, which fell to NIS 16.1 million from NIS 26.5 million, partly because FX shifted from a tailwind to a headwind.

The product mix sharpens the picture further. Sweet beverages rose to NIS 567.2 million and accounted for 72% of sales, up from 69% in 2024, while water and soda fell to NIS 217.1 million and accounted for 28%. That is an important mix change, because water and soda carry lower gross profitability. At the same time, Yafora began launching reduced-sugar recipes from December 2024 across Tepuzina, Schweppes, and Crystal. That is not a new growth engine, but it does show a company adapting to regulatory and consumer pressure rather than standing still.

There is also a weakness here that needs to be stated plainly. The report itself says the energy-drinks category has been growing for years, including in 2024 and 2025, and then notes that Yafora does not market energy drinks. That does not mean the company is failing. It does mean the business is defending its core through brands, flavors, reduced-sugar reformulations, and distribution, rather than riding every growth pocket in the market. Future upside has to come mostly from better execution, not from a new category suddenly changing the story.

Sales channels also shifted. In 2025, 47% of sales came from the organized market, up from 40% in 2024, while the private market fell to 40% from 48%. Independent agents stayed around 13%. A shift like that does not automatically mean better quality. It does mean the large chains carry more weight. In a market where competition is intense, private labels continue to penetrate, and disagreements with a large retailer can hurt revenue and profit, this is a mix shift that demands stronger commercial discipline.

On the other side of the ledger, there are clear quality points. No single customer accounted for more than 10% of sales, and the group is not dependent on any one agent. Yafora is still one of the three largest soft-drink producers in Israel, with about 15.9% share in value terms and 26.2% in volume terms in the barcoded market. That is a real moat, but not a quiet one. It must be defended through advertising, product development, pricing discipline, and a reliable distribution network.

The most interesting operating datapoint may actually be the absence of a story. Yafora has no backlog. Sales are immediate, and orders that can still be cancelled are not counted as backlog. That matters because it forces investors to read Krur like a beverage company, not like a project or backlog story. There is no multiyear visibility doing the analytical work here. If the next quarter is weak, the business will feel it quickly.

Capacity tells a similarly two-sided story. Yafora used only about 65% of production capacity on average in 2025, which means there is room to grow without an immediate jump in fixed-cost pressure. At the same time, the company already replaced several production lines in 2025 and plans additional replacements in 2026. That is positive, because it points to better technology and efficiency, but it also means the next year will be judged not only by sales, but by the ability to execute upgrades without causing operational disruption.

The quarterly chart shows the issue clearly. In Q3, operating profit reached NIS 42.7 million. In Q4, it fell to just NIS 12.0 million on revenue of NIS 178.7 million and a 6.7% operating margin. That does not necessarily define the new normal, but it is not noise that should be ignored. It is a reminder that the core remains sensitive to one-offs, seasonality, regulation, and competition.

Cash Flow, Debt and Capital Structure

Krur in 2025 has to be read through two different cash lenses. The first is recurring cash generation. Cash flow from operations was NIS 112.5 million, down 19.7% from NIS 140.0 million in 2024. That is still respectable, but it clearly says the business generated less recurring operating cash than the year before.

The second lens, and the more relevant one here, is all-in cash flexibility after actual cash uses. After reported CAPEX of NIS 39.3 million, lease cash payments of NIS 24.4 million, and a NIS 35.0 million dividend to Krur shareholders, only about NIS 13.8 million of all-in flexibility remained in 2025. A year earlier that figure was about NIS 37.1 million. In other words, consolidated cash still rose to NIS 577.8 million, but the room left after real cash uses actually narrowed.

This is exactly why Tifugan matters more than the December 31 snapshot. At year-end, Krur’s share in Tifugan was still carried at NIS 84.1 million on the balance sheet. On January 1, 2026, that position translated into NIS 163.5 million of cash to the company and another NIS 43.7 million due a year later. That is the move from accounting value to cash actually available at the parent.

This is also the critical distinction between value created and value accessible. While Tifugan remained only an equity-accounted investment, investors could talk about asset quality, but not about liquidity for Krur shareholders. Now the conversion has taken place. That supports the thesis, but it also raises the analytical bar. Once value becomes cash, the debate shifts to dividends, balance-sheet policy, reinvestment, and whether management avoids a new strategic distraction.

From a leverage perspective, Krur does not look stressed. Short-term bank borrowings at year-end were only NIS 862 thousand and were fully repaid at the start of 2026 once the Tifugan cash arrived. Long-term loans stood at NIS 11.1 million. Lease liabilities were roughly NIS 78.0 million in total. This is not a refinancing-pressure story. The yellow flag here is not debt. It is temptation. After a successful monetization, management can either become more disciplined or go looking for the next idea. Green Pet is the reminder of why that distinction matters.

Green Pet also sharpens the capital-discipline question. The business was originally framed as a strategic complement to Yafora. Then it turned into a loss-making activity with a major customer, Retal, that had accounted for 65.5% of 2024 sales and cut purchases, while the economic gap between virgin PET and recycled PET remained too wide. The result was decisive: full closure, right-of-use asset write-offs, full impairment of the main equipment, and still no relevant buyer for the main equipment by the report date. This was a painful clean-up, but still better than a prolonged sunk-cost story.

Outlook

Before getting into the forecast itself, four non-obvious takeaways matter most:

• Takeaway one: 2026 will probably look stronger before it becomes cleaner.
• Takeaway two: Yafora has spare capacity, but Q4 showed that operating margin is not on autopilot.
• Takeaway three: Krur is no longer mainly a portfolio story. It is now a capital-allocation story.
• Takeaway four: Green Pet has been shut down, but not every cost of that chapter is necessarily behind the company as long as the equipment still has to be monetized.

That is why 2026 looks like a bridge year with a proof requirement. The structural transition has already happened: less portfolio, more beverages, more cash at the parent. The proof point has not happened yet at the earnings-quality level. The market will want to see that Yafora can sustain decent profitability without Tifugan, after the loss of Mey Eden distribution, and without leaning on one-off headlines.

The first hurdle is core profitability. In 2025, gross margin improved, but operating margin weakened and Q4 was soft. If Q1 and Q2 of 2026 show a recovery to more comfortable operating levels, investors can argue that late-2025 weakness was a blend of the fine, seasonality, and transition noise. If not, the market will have to consider that Yafora’s earnings base is not as robust as the brands and market share suggest.

The second hurdle is the quality of translating the Tifugan deal into usable cash. As of the report date, Krur expects about NIS 123 million of pre-tax capital gain in Q1 2026, after already paying around NIS 34 million of tax on a tax gain of about NIS 192 million. But here too, accounting profit and accessible cash are not the same thing. The immediate cash is already in. The deferred payment still has to be collected. Most importantly, capital-allocation policy has not yet been delivered.

The third hurdle is execution. The line replacements completed in 2025 and planned for 2026 are meant to improve technology, productivity, and efficiency. That sounds positive, and it usually is. But in the short term, such moves can also create downtime, operating complexity, or higher inventory buffers. The market will not give credit for new lines unless that shows up in the operating result.

The fourth hurdle is external. The company itself points to several forces outside its control: the possible return of the sugar tax, the effect of the war on demand and on geographic sales areas, collection limits in the Palestinian Authority, imported input costs, FX volatility, and higher energy and freight costs. In 2025, net finance income already weakened in part because FX moved the wrong way. That is a reminder that a sizable cash balance does not immunize the beverage core from margin pressure.

In that sense, the market may focus on the wrong thing near term. Q1 2026 will probably be framed around the Tifugan capital gain. The more important question will be whether Yafora is back to a more comfortable double-digit operating margin and what signal investors receive about the use of cash. A special dividend, balance-sheet conservatism, or clearly disciplined capital allocation would strengthen the read. Ambiguity, delay, or a new strategic adventure would weaken it.

Risks

The first risk is earnings-quality risk, not earnings-existence risk. The coming year will likely contain a large one-off capital gain, which means it will be easier to show improvement in the bottom line than to prove real improvement in business quality. If investors do not normalize that gain and focus on the beverage core, they may end up with too optimistic a picture.

The second risk is regulatory and commercial. Yafora operates in a very competitive industry, remains exposed to sugar-tax policy, private-label pressure, and commercial relationships with large chains. The Competition Authority fine is a reminder that regulatory friction is not theoretical. It has already cost money.

The third risk is external exposure. Some raw materials are imported, a weaker shekel hurts costs, and sales into the Palestinian Authority and East Jerusalem are exposed both to security events and to collection and bank-transfer constraints. The group is also exposed to Ein Gedi’s water-source profile, and the Rehovot plant has physical expansion constraints because of its proximity to residential areas.

The fourth risk is capital allocation itself. After a successful monetization, the market sometimes gives management early credit for the next move. That is dangerous. Green Pet shows that something framed as a strategic complement can still end in closure, impairment, and losses. Every use of the new cash therefore has to be judged not by its narrative, but by its return profile and the risk it adds.

The fifth risk is market structure. With trading liquidity this low, even a good thesis can take a long time to be reflected in price, while a weaker thesis can break without real exit liquidity. That is not a business risk, but it is an actionability risk for shareholders.

Conclusions

Krur ends 2025 with a report that looks weaker than the underlying economics really are. Green Pet dragged reported earnings lower, but at the same time the company completed the Tifugan sale and was left with a much clearer beverage-centered structure. That supports a simpler-business thesis, but not yet a fully clean-business thesis.

Current thesis: Krur is moving from a multi-layered holdings story to a beverage platform with a large cash event, so the analytical focus has shifted from asset ownership to capital-allocation discipline and the earnings quality of Yafora.

What has changed versus the older way of reading Krur is straightforward. Before, investors had to ask how much Tifugan was worth, whether Green Pet was a real option, and how much of the group was carried by Yafora alone. Now Tifugan is already close to cash, Green Pet is already out of the story, and Yafora is the story. That is an improvement in structure, but not the end of the debate.

The strongest counter-thesis is that the market may be too quick to read 2026 as a year of value release, when in reality Krur is left with a beverage business that is still highly competitive and sensitive to regulation, FX, imported inputs, and retailer bargaining power. If that happens, the capital gain will flatter the headline without actually changing business quality.

What can change market interpretation in the short to medium term is not just the capital gain itself, but mainly what management does after it. Distribution, balance-sheet conservatism, or a disciplined use of cash would improve the read. Ambiguity, delay, or a new strategic detour would weigh on it.

Why does this matter? Because Krur is at a rare point where value does not need to be created from scratch. It mainly needs to be translated correctly. If that translation works, shareholders are left with a simpler business and more accessible cash. If it does not, the 2025 report will prove to be an accounting bridge rather than a qualitative turning point.

Over the next 2 to 4 quarters, Krur has four clear hurdles: Yafora needs to recover to a more comfortable operating margin, the deferred Tifugan consideration needs to turn into cash without unpleasant surprises, Green Pet needs to move from operational closure to full financial clean-up, and management needs to give the market a clear capital-allocation message. If those things happen, the thesis strengthens materially. If not, it will turn out that structural simplification came well before economic simplification.